Core outcome measures for chronic pain clinical trials: IMMPACT recommendations RH Dworkin, DC Turk, JT Farrar, JA Haythornthwaite, MP Jensen, ... pain 113 (1-2), 9-19, 2005 | 4300 | 2005 |
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations RH Dworkin, M Backonja, MC Rowbotham, RR Allen, CR Argoff, ... Archives of neurology 60 (11), 1524-1534, 2003 | 2000 | 2003 |
Core outcome domains for chronic pain clinical trials: IMMPACT recommendations DC Turk, RH Dworkin, RR Allen, N Bellamy, N Brandenburg, DB Carr, ... Pain 106 (3), 337-345, 2003 | 1504 | 2003 |
Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale BS Galer, MP Jensen Neurology 48 (2), 332-338, 1997 | 1037 | 1997 |
Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life BS Galer, A Gianas, MP Jensen Diabetes research and clinical practice 47 (2), 123-128, 2000 | 894 | 2000 |
External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria S Bruehl, RN Harden, BS Galer, S Saltz, M Bertram, M Backonja, ... Pain 81 (1-2), 147-154, 1999 | 857 | 1999 |
Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia MC Rowbotham, PS Davies, C Verkempinck, BS Galer Pain 65 (1), 39-44, 1996 | 721 | 1996 |
Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study BS Galer, MC Rowbotham, J Perander, E Friedman Pain 80 (3), 533-538, 1999 | 634 | 1999 |
Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients G Allen, BS Galer, L Schwartz Pain 80 (3), 539-544, 1999 | 511 | 1999 |
Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive? RN Harden, S Bruehl, BS Galer, S Saltz, M Bertram, M Backonja, ... Pain 83 (2), 211-219, 1999 | 506 | 1999 |
Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome? S Bruehl, RN Harden, BS Galer, S Saltz, M Backonja, M Stanton-Hicks Pain 95 (1-2), 119-124, 2002 | 424 | 2002 |
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial L Lagae, J Sullivan, K Knupp, L Laux, T Polster, M Nikanorova, ... The Lancet 394 (10216), 2243-2254, 2019 | 347 | 2019 |
Neglect-like symptoms in complex regional pain syndrome: results of a self-administered survey BS Galer, M Jensen Journal of pain and symptom management 18 (3), 213-217, 1999 | 342 | 1999 |
The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the … BS Galer, MP Jensen, T Ma, PS Davies, MC Rowbotham The Clinical journal of pain 18 (5), 297-301, 2002 | 334 | 2002 |
Individual variability in the response to different opioids: report of five cases BS Galer, N Coyle, GW Pasternak, RK Portenoy Pain 49 (1), 87-91, 1992 | 330 | 1992 |
Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study A Devers, BS Galer The Clinical journal of pain 16 (3), 205-208, 2000 | 318 | 2000 |
Neuropathic pain of peripheral origin: advances in pharmacologic treatment BS Galer Neurology 45 (12_suppl_9), S17-S25, 1995 | 299 | 1995 |
Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia PS Davies, BS Galer Drugs 64, 937-947, 2004 | 275 | 2004 |
Case reports and hypothesis: a neglect-like syndrome may be responsible for the motor disturbance in reflex sympathetic dystrophy (Complex Regional Pain Syndrome-1) BS Galer, S Butler, MP Jensen Journal of pain and symptom management 10 (5), 385-391, 1995 | 275 | 1995 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature AR Gammaitoni, NA Alvarez, BS Galer The Journal of Clinical Pharmacology 43 (2), 111-117, 2003 | 273 | 2003 |